Business & Finance
Veklury Significantly Reduced Risk of Hospitalization in High-Risk Patients with COVID-19
23 September 2021 - - US-based Gilead Sciences, Inc. (NASDAQ: GILD) has posted positive results from a Phase 3 randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of...
Pfizer, BioNTech Expand Collaboration with US to Provide 500 m Additional COVID-19 Vaccine Doses at Not-for-Profit Price for Donation to Poorest Countries
22 September 2021 - - US-based pharmaceutical company Pfizer Inc. (NYSE: PFE) and German biotechnology company BioNTech SE (NASDAQ: BNTX) plan to expand their agreement with the US government by provi...
Abbott announces quarterly common dividend
16 September 2021 - Abbott (NYSE: ABT), a global healthcare company, announced on Wednesday its quarterly common dividend.The company has declared a dividend of USD0.45 per share.The dividend will be ...
BIOCORP partners with MERCK for Mallya for Human Growth Hormone (HGH)
16 September 2021 - French medical company BIOCORP (FR0012788065 – ALCOR) said on Thursday that it will develop and supply a specific version of its Mallya device to monitor treatment adherence ...
US government buys 388,000 additional doses of Eli Lilly's COVID-19 antibody therapy
15 September 2021 - The US government has purchased 388,000 additional doses of US pharmaceutical company Eli Lilly and Company's (Lilly) (NYSE:LLY) COVID-19 antibody therapy, Reuters news agency...
EU to donate an additional 200 million COVID-19 vaccine doses to poorer countries
15 September 2021 - The executive chief of the European Union has said that the EU will donate a further 200 million COVID-19 vaccine doses to poorer countries and close gaps in its own vaccination co...